Calypte developing urine-based home HIV test service.
This article was originally published in The Tan Sheet
Executive Summary
CALYPTE DEVELOPING URINE-BASED HOME HIV TEST SERVICE, the company said in a registration statement for its initial public offering. The firm plans to use approximately $4 mil. of net proceeds from the offering to establish a reference laboratory where consumers will mail urine samples for testing, the company stated. The move represents part of a broader effort at Calypte to develop a home HIV test service.